Infuenza

Influenza A

August 15, 20240 min read

An Influenza A expert working at the Pasteur Institute has demonstrated and had approved a protocol for the inactivation of Influenza A virus (plaque forming assay with A549 cells) using vivoPHIX. 

 This has provided her with a safe way to handle and transport cells that have been infected with the virus.

influenza

Back to Blog


RNAssist technology supports a wide range of life science applications, including tissue fixation and dissociation, single-cell multiomics (scRNA-seq, CITE-seq), and virus inactivation and transport for enhanced diagnostic testing.

Follow us on LinkedIn

© RNAssist | www.RNAssist.com